Skip to main content
logo
Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
13.07
+0.89 (7.31%)
At close: Feb 6, 2026, 4:00 PM EST
13.02
-0.05 (-0.38%)
After-hours: Feb 6, 2026, 7:50 PM EST

Janux Therapeutics Revenue

Janux Therapeutics had revenue of $10.00M in the quarter ending September 30, 2025, with 2,177.90% growth. This brings the company's revenue in the last twelve months to $10.00M, down -23.37% year-over-year. In the year 2024, Janux Therapeutics had annual revenue of $10.59M with 30.99% growth.

Revenue (ttm)
$10.00M
Revenue Growth
-23.37%
P/S Ratio
79.26
Revenue / Employee
$91,743
Employees
109
Market Cap
786.13M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202410.59M2.51M30.99%
Dec 31, 20238.08M-529.00K-6.14%
Dec 31, 20228.61M4.98M136.79%
Dec 31, 20213.64M--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
MiMedx Group393.44M
Valneva SE211.09M
Maravai LifeSciences Holdings192.44M
Xencor150.13M
Nektar Therapeutics62.60M
KalVista Pharmaceuticals1.43M
YD Bio510.36K
Revenue Rankings

JANX News

More News